The Role of 18F-FDG PET/CT in Guiding Precision Medicine for Invasive Bladder Carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of 18F-FDG PET/CT in Guiding Precision Medicine for Invasive Bladder Carcinoma
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-10-06
DOI
10.3389/fonc.2020.565086
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pilot Study of [18F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC)
- (2020) Patrick J. Eulitt et al. Clinical Genitourinary Cancer
- Diagnosis of Hyper-progressive Disease in Patients Treated with Checkpoint Inhibitors using 18F-FDG PET/CT
- (2020) Romain-David Seban et al. JOURNAL OF NUCLEAR MEDICINE
- Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4
- (2020) Romain-David Seban et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma
- (2020) Pei Nie et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Elaboration of a multisequence MRI-based radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer: a double-center study
- (2020) Huanjun Wang et al. EUROPEAN RADIOLOGY
- European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
- (2020) J. Alfred Witjes et al. EUROPEAN UROLOGY
- Utility of Routine Preoperative 18 F-Fluorodeoxyglucose Positron Emission Tomography-Computerized Tomography in Identifying Pathological Lymph Node Metastases at Radical Cystectomy
- (2020) Shawn Dason et al. JOURNAL OF UROLOGY
- Polygenic risk for skin autoimmunity impacts immune checkpoint blockade in bladder cancer
- (2020) Zia Khan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Machine learning-based analysis of [18F]DCFPyL PET radiomics for risk stratification in primary prostate cancer
- (2020) Matthijs C. F. Cysouw et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- CT-based radiomics to predict the pathological grade of bladder cancer
- (2020) Gumuyang Zhang et al. EUROPEAN RADIOLOGY
- Relationship between the expression of PD-1/PD-L1 and 18F-FDG uptake in bladder cancer
- (2019) Ruohua Chen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Integrated analysis of 18F-FDG PET/CT improves preoperative lymph node staging for patients with invasive bladder cancer
- (2019) Antoine Girard et al. EUROPEAN RADIOLOGY
- Unconventional immune-related phenomena observed using 18F-FDG PET/CT in Hodgkin lymphoma treated with anti PD-1 monoclonal antibodies
- (2019) Laurent Dercle et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comment on: Relationship between the expression of PD-1/PD-L1 and 18F-FDG uptake in bladder cancer
- (2019) Antoine Girard et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 18F-FDG PET/CT and Urothelial Carcinoma: Impact on Management and Prognosis—A Multicenter Retrospective Study
- (2019) Fabio Zattoni et al. Cancers
- Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics
- (2019) Romain-David Seban et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Effectiveness of First-line Immune Checkpoint Blockade Versus Carboplatin-based Chemotherapy for Metastatic Urothelial Cancer
- (2019) Emily Feld et al. EUROPEAN UROLOGY
- 18FDG PET/CT in the early assessment of non-small cell lung cancer response to immunotherapy: frequency and clinical significance of atypical evolutive patterns
- (2019) O. Humbert et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors
- (2019) Romain-David Seban et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Good clinical practice recommendations for the use of PET/CT in oncology
- (2019) Pierre-Yves Salaün et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†
- (2019) J. Alfred Witjes et al. EUROPEAN UROLOGY
- Delayed 18F FDG PET/CT Imaging in the Assessment of Residual Tumors after Transurethral Resection of Bladder Cancer
- (2019) Hui Yan et al. RADIOLOGY
- Evaluation of 2 diuretic 18fluorine-fluorodeoxyglucose positron emission tomography/computed tomography imaging protocols for intrapelvic cancer
- (2019) Lawrence O. Dierickx et al. The quarterly journal of nuclear medicine and molecular imaging
- Prognostic Value of Baseline Total Metabolic Tumor Volume Measured on FDG PET in Patients With Richter Syndrome
- (2019) Clémence Pontoizeau et al. CLINICAL NUCLEAR MEDICINE
- The Diagnostic Performance of MRI for Detection of Lymph Node Metastasis in Bladder and Prostate Cancer: An Updated Systematic Review and Diagnostic Meta-Analysis
- (2018) Sungmin Woo et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Detectability of residual invasive bladder cancer in delayed 18F-FDG PET imaging with oral hydration using 500 mL of water and voiding-refilling
- (2018) Akira Higashiyama et al. ANNALS OF NUCLEAR MEDICINE
- FDG-PET/CT for Assessing the Response to Neoadjuvant Chemotherapy in Bladder Cancer Patients
- (2018) Ayman Soubra et al. Clinical Genitourinary Cancer
- Increased Utilization of Positron Emission Tomography/Computed Tomography (PET/CT) Imaging and Its Economic Impact for Patients Diagnosed With Bladder Cancer
- (2018) Jinhai Huo et al. Clinical Genitourinary Cancer
- Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1
- (2018) Ahmed Mekki et al. EUROPEAN JOURNAL OF CANCER
- Diagnostic Accuracy of F-18 FDG PET/CT for Preoperative Lymph Node Staging in Newly Diagnosed Bladder Cancer Patients: A Systematic Review and Meta-Analysis
- (2018) Hong Ku Ha et al. ONCOLOGY
- Development of immunotherapy in bladder cancer: present and future on targeting PD(L)1 and CTLA-4 pathways
- (2018) Mathieu Rouanne et al. WORLD JOURNAL OF UROLOGY
- Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer
- (2018) Francesco Soria et al. WORLD JOURNAL OF UROLOGY
- ACR Appropriateness Criteria ® Pretreatment Staging of Muscle-Invasive Bladder Cancer
- (2018) Christian B. van der Pol et al. Journal of the American College of Radiology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- NCCN Guidelines Insights: Bladder Cancer, Version 5.2018
- (2018) Thomas W. Flaig et al. Journal of the National Comprehensive Cancer Network
- 11C-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial)
- (2018) Antti Salminen et al. CANCER IMAGING
- Development and Validation of an MRI-Based Radiomics Signature for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer
- (2018) Shaoxu Wu et al. EBioMedicine
- Diagnostic Accuracy of CT for Prediction of Bladder Cancer Treatment Response with and without Computerized Decision Support
- (2018) Kenny H. Cha et al. ACADEMIC RADIOLOGY
- FDG PET/CT for assessing tumour response to immunotherapy
- (2018) Nicolas Aide et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prediction of Lymph Node Maximum Standardized Uptake Value in Patients With Cancer Using a 3D Convolutional Neural Network: A Proof-of-Concept Study
- (2018) Hiram Shaish et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy
- (2017) E. E. Fransen van de Putte et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- 18F-FDG PET and CT Scans Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti–Programmed Death 1 Immune Checkpoint Inhibitor
- (2017) Laurent Dercle et al. JOURNAL OF NUCLEAR MEDICINE
- Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition
- (2017) Arlene Siefker-Radtke et al. Nature Reviews Urology
- [18F]Fluorodeoxyglucose-positron emission tomography/computed tomography response evaluation can predict histological response at surgery after induction chemotherapy for oligometastatic bladder cancer
- (2017) Petter Kollberg et al. Scandinavian Journal of Urology
- Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1
- (2016) Stéphane Champiat et al. CLINICAL CANCER RESEARCH
- Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT
- (2016) Pierpaolo Alongi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Metabolic alterations in bladder cancer: applications for cancer imaging
- (2016) Terry Whyard et al. EXPERIMENTAL CELL RESEARCH
- Bladder cancer
- (2016) Ashish M Kamat et al. LANCET
- The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis
- (2016) Ayman Soubra et al. WORLD JOURNAL OF UROLOGY
- Is [F-18]-fluorodeoxyglucose FDG-PET/CT better than ct alone for the preoperative lymph node staging of muscle invasive bladder cancer?
- (2016) Mete Uttam et al. International Braz J Urol
- FDG PET–CT for Lymph Node Staging of Bladder Cancer: A Prospective Study of Patients with Extended Pelvic Lymphadenectomy
- (2015) In Gab Jeong et al. ANNALS OF SURGICAL ONCOLOGY
- 11C-Choline PET/CT and Bladder Cancer
- (2015) Francesco Ceci et al. CLINICAL NUCLEAR MEDICINE
- 11C-Choline PET/CT for Restaging of Bladder Cancer
- (2015) Tiziano Graziani et al. CLINICAL NUCLEAR MEDICINE
- Comparing RECIST with EORTC criteria in metastatic bladder cancer
- (2015) Hakan Öztürk JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Pseudoprogression and Immune-Related Response in Solid Tumors
- (2015) Victoria L. Chiou et al. JOURNAL OF CLINICAL ONCOLOGY
- Value of positron emission tomography in diagnosing synchronous penile metastasis from urothelial bladder cancer
- (2015) M. Rouanne et al. World Journal of Surgical Oncology
- Efficacy of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in restaging muscle-invasive bladder cancer following radical cystectomy
- (2015) HAKAN ÖZTÜRK et al. Experimental and Therapeutic Medicine
- PET/CT versus conventional CT for detection of lymph node metastases in patients with locally advanced bladder cancer
- (2015) Firas Aljabery et al. BMC Urology
- Detecting Metastatic Bladder Cancer Using 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography
- (2015) Hakan Öztürk Cancer Research and Treatment
- Interim Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography for Early Metabolic Assessment of Therapeutic Response to Chemotherapy for Metastatic Transitional Cell Carcinoma
- (2014) Patrizia Giannatempo et al. Clinical Genitourinary Cancer
- Feasible Method to enable clear visualization of suspected bladder cancer with 18F-FDG PET/CT
- (2014) Na Fang et al. CLINICAL IMAGING
- Diagnostic Accuracy of 11C-Choline PET/CT in Preoperative Lymph Node Staging of Bladder Cancer
- (2014) Eugenio Brunocilla et al. CLINICAL NUCLEAR MEDICINE
- Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy
- (2014) M. Rouanne et al. EJSO
- Prognostic Value of 11C-Choline PET/CT and CT for Predicting Survival of Bladder Cancer Patients Treated with Radical Cystectomy
- (2014) Tobias Maurer et al. UROLOGIA INTERNATIONALIS
- 18F-fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography Aids Staging and Predicts Mortality in Patients With Muscle-invasive Bladder Cancer
- (2014) Laura S. Mertens et al. UROLOGY
- Impact of18F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle
- (2013) Laura S. Mertens et al. BJU INTERNATIONAL
- Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer
- (2013) Henry Goodfellow et al. BJU INTERNATIONAL
- Influences of point-spread function and time-of-flight reconstructions on standardized uptake value of lymph node metastases in FDG-PET
- (2013) Go Akamatsu et al. EUROPEAN JOURNAL OF RADIOLOGY
- Is Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Useful for Detecting Bladder Lesions? A Meta-Analysis of the Literature
- (2013) Ningjian Wang et al. UROLOGIA INTERNATIONALIS
- Is whole-body fluorine-18 fluorodeoxyglucose PET/CT plus additional pelvic images (oral hydration–voiding–refilling) useful for detecting recurrent bladder cancer?
- (2012) Zhongyi Yang et al. ANNALS OF NUCLEAR MEDICINE
- Early Dynamic PET/CT and 18F-FDG Blood Flow Imaging in Bladder Cancer Detection
- (2012) Sam Belakhlef et al. CLINICAL NUCLEAR MEDICINE
- Diuretic 18F-FDG PET/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique
- (2012) Brusabhanu Nayak et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prospective evaluation of MRI, 11C-acetate PET/CT and contrast-enhanced CT for staging of bladder cancer
- (2012) H.A. Vargas et al. EUROPEAN JOURNAL OF RADIOLOGY
- Clinical value of whole body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of metastatic bladder cancer
- (2012) Zhongyi Yang et al. INTERNATIONAL JOURNAL OF UROLOGY
- 18F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: A prospective study
- (2012) Maryam Hitier-Berthault et al. INTERNATIONAL JOURNAL OF UROLOGY
- FDG-Positron Emission Tomography/Computerized Tomography for Monitoring the Response of Pelvic Lymph Node Metastasis to Neoadjuvant Chemotherapy for Bladder Cancer
- (2012) Laura S. Mertens et al. JOURNAL OF UROLOGY
- Catheter-assisted 18F-FDG-PET/CT imaging of primary bladder cancer
- (2012) Laura S. Mertens et al. NUCLEAR MEDICINE COMMUNICATIONS
- Diagnostic Efficacy of [11C]Choline Positron Emission Tomography/Computed Tomography Compared With Conventional Computed Tomography in Lymph Node Staging of Patients With Bladder Cancer Prior to Radical Cystectomy
- (2011) Tobias Maurer et al. EUROPEAN UROLOGY
- Comparison of 11C-Choline With 18F-FDG in Positron Emission Tomography/Computerized Tomography for Staging Urothelial Carcinoma: A Prospective Study
- (2011) Shay Golan et al. JOURNAL OF UROLOGY
- Initial Results with 11C-Acetate Positron Emission Tomography/Computed Tomography (PET/CT) in the Staging of Urinary Bladder Cancer
- (2011) Heiko Schöder et al. MOLECULAR IMAGING AND BIOLOGY
- Preoperative lymph-node staging of invasive urothelial bladder cancer with18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: Correlation with histopathology
- (2011) Thor Knak Jensen et al. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
- Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer
- (2010) Andrea B. Apolo et al. JOURNAL OF CLINICAL ONCOLOGY
- FDG-PET/CT for the Preoperative Lymph Node Staging of Invasive Bladder Cancer
- (2009) Greet Swinnen et al. EUROPEAN UROLOGY
- Prospective Study of [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Staging of Muscle-Invasive Bladder Carcinoma
- (2009) Adam S. Kibel et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started